RECORD // Company

Angiodynamics Inc

Built 2026-11-21T07:57:30Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
  • Angiodynamics, Inc. · legal entity in this company's GLEIF ownership tree (LEI 549300W3VKC5ZKMO8C28)
SEC EDGAR (1)
Matched by name only, not merged (15)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • ANGIODYNAMICS INC · Brla parish businesses · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Angiodynamics · Ca business · exact name match to 'ANGIODYNAMICS INC' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS · Ca payments · exact name match to 'ANGIODYNAMICS INC' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS INC · Ca payments · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • AngioDynamics, Inc. · Corp enforcement · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • AngioDynamics, Inc. · Corp enforcement · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Angiodynamics, Inc. · Ctgov · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS, INC. · East licences · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS · Epa echo · exact name match to 'ANGIODYNAMICS INC' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS · Epa echo · exact name match to 'ANGIODYNAMICS INC' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS INC · Epa echo · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS INC · Epa echo · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS INC. · Mw licenses · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS, INC. · Ny corps · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANGIODYNAMICS INC · USAspending · same registered legal name as 'ANGIODYNAMICS INC' Possible match based on name, not a shared identifier. Compare the records. Compare

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-08-31, filed 2026-10-08 · accession 0001628280-26-065423

ItemValuePeriodFormFiledAccessionReport
Revenue$80,915,0003 months ended 2026-08-3110-Q2026-10-080001628280-26-0654232026-11-21 07:57 UTCReport an error
Net income (loss)$-7,097,0003 months ended 2026-08-3110-Q2026-10-080001628280-26-0654232026-11-21 07:57 UTCReport an error
Cash and cash equivalents$33,973,000at 2026-08-3110-Q2026-10-080001628280-26-0654232026-11-21 07:57 UTCReport an error
Contract liabilities (total)$343,000at 2026-08-3110-Q2026-10-080001628280-26-0654232026-11-21 07:57 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001275187
Ticker
ANGO
EIN
113146460
CUSIP
03475V101
Record ID
sx:sec:0001275187

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

31 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-18SEC EDGAR company profile2026-11-21 07:57 UTCReport an error
SIC industry3841 Surgical & Medical Instruments & Apparatus2026-11-18SEC EDGAR company profile2026-11-21 07:57 UTCReport an error
State of incorporationDE2026-11-18SEC EDGAR company profile2026-11-21 07:57 UTCReport an error
Fiscal year end (MMDD)05312026-11-18SEC EDGAR company profile2026-11-21 07:57 UTCReport an error
Business address14 PLAZA DRIVE, LATHAM, NY, 121102026-11-18SEC EDGAR company profile2026-11-21 07:57 UTCReport an error
ExchangesNasdaq2026-11-18SEC EDGAR company profile2026-11-21 07:57 UTCReport an error
Revenue (fiscal year ended 2026-05-31)$320,174,0002026-05-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-21 07:57 UTCReport an error
Net income (loss) (fiscal year ended 2026-05-31)$-36,742,0002026-05-3110-K/A, XBRL NetIncomeLoss2026-11-21 07:57 UTCReport an error
Total assets (at 2026-05-31)$267,163,0002026-05-3110-K, XBRL Assets2026-11-21 07:57 UTCReport an error
Stockholders' equity (at 2026-05-31)$170,825,0002026-05-3110-K, XBRL StockholdersEquity2026-11-21 07:57 UTCReport an error
Cash and cash equivalents (at 2026-05-31)$53,864,0002026-05-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 07:57 UTCReport an error
Operating cash flow (fiscal year ended 2026-05-31)$3,089,0002026-05-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 07:57 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2026-05-31)$2,581,0002026-05-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 07:57 UTCReport an error
Operating lease liabilities (at 2026-05-31)$5,156,0002026-05-3110-K, XBRL OperatingLeaseLiability2026-11-21 07:57 UTCReport an error
8-K Item 5.02 (filed 2026-11-18)Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (e) As described below, the shareholders of AngioDynamics, Inc. (“AngioDynamics”) voted on November 17, 2026 to approve the amended AngioDynamics, Inc. 2020 Equity Incentive Plan (the “2020 Plan”) to increase the number of shares available for issuance. The material terms of the 2020 Plan are described in Proposal 4 included in AngioDynamics’ definitive proxy statement filed with the Securities and Exchange Commission on October 8, 2026, which description does not purport to be complete and is qualified in its entirety by reference to the full…2026-11-18SEC EDGAR 8-K 0001140361-26-044750 (text as filed, excerpt)2026-11-21 07:57 UTCReport an error
8-K Item 5.07 (filed 2026-11-18)Submission of Matters to a Vote of Security Holders. (a) The Annual Meeting of Shareholders of AngioDynamics was held on November 17, 2026. (b) Shareholders of AngioDynamics voted on the matters set forth below. 1. The nominees for election to the Board of Directors were elected, each as a Class II director to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, based upon the following votes: Nominee Votes For Withheld Broker Non-Votes Eileen O. Auen 28,252,245 2,555,472 5,872,140 Jan Stern Reed 27,956,254 2,851,463 5,872,140 2. The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics’ independent…2026-11-18SEC EDGAR 8-K 0001140361-26-044750 (text as filed, excerpt)2026-11-21 07:57 UTCReport an error
8-K Item 2.02, – Results of Operations and Financial Condition (filed 2026-10-08)On October 8, 2026, AngioDynamics, Inc. (“AngioDynamics”) issued a press release announcing financial results for the fiscal first quarter ended August 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1. The information set forth in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, such information shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as…2026-10-08SEC EDGAR 8-K 0001140361-26-039020 (text as filed, excerpt)2026-11-21 07:57 UTCReport an error
8-K Item 7.01, – Regulation FD Disclosure (filed 2026-10-08)Presentation slides discussing AngioDynamics and its fiscal first quarter ended August 31, 2026 are furnished herewith as Exhibit 99.2. The presentation slides furnished pursuant to Item 7.01 of this Form 8-K (including Exhibit 99.2) shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section. Furthermore, the presentation slides shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act. Forward-Looking Statements This document and its attachments contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All…2026-10-08SEC EDGAR 8-K 0001140361-26-039020 (text as filed, excerpt)2026-11-21 07:57 UTCReport an error
8-K Item 1.01, – Entry into a Material Definitive Agreement (filed 2026-10-08)On October 3, 2026, AngioDynamics, Inc. (“AngioDynamics” or the “Company”) entered into an employment agreement with Eric Honroth (the “Employment Agreement”), pursuant to which Mr. Honroth will serve as President and Chief Executive Officer of the Company. A description of the Employment Agreement is contained in Item 5.02 below, which is incorporated by reference into this Item 1.01. A copy of the Employment Agreement is attached to this Current Report on Form 8-K as Exhibit 10.1, and the terms of the Employment Agreement are incorporated herein by this reference.2026-10-08SEC EDGAR 8-K 0001140361-26-039019 (text as filed, excerpt)2026-11-21 07:57 UTCReport an error
8-K Item 5.02, – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain (filed 2026-10-08)Officers. CEO Appointment As previously disclosed, James C. Clemmer has announced his intention to retire from his position as the President and Chief Executive Officer of the Company on the earlier of November 30, 2026 and appointment of a successor Chief Executive Officer. Mr. Clemmer has served as the Company’s President and Chief Executive Officer since April 2016. On October 2, 2026, the Board of Directors of the Company (the “Board”) appointed Eric Honroth to serve as President and Chief Executive Officer of the Company, effective as of November 2, 2026 (the “Effective Date”) and concurrently with Mr. Clemmer’s retirement. Prior to his appointment as President and Chief Executive…2026-10-08SEC EDGAR 8-K 0001140361-26-039019 (text as filed, excerpt)2026-11-21 07:57 UTCReport an error
Plan (pension, plan no. 001)ANGIODYNAMICS, INC. RETIREMENT AND SAVINGS PLAN: 1,062 participants, assets $147,455,4332025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 07:57 UTCReport an error
Largest institutional holder #1 (13F as filed): BlackRock, Inc.$49,480,0482026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error
Largest institutional holder #2 (13F as filed): Point72 Asset Management, L.P.$39,843,3462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error
Largest institutional holder #3 (13F as filed): SYSTEMATIC FINANCIAL MANAGEMENT LP$34,349,1992026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error
Largest institutional holder #4 (13F as filed): ARMISTICE CAPITAL, LLC$28,595,9802026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error
Largest institutional holder #5 (13F as filed): ROYCE & ASSOCIATES LP$25,627,5532026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error
Largest institutional holder #6 (13F as filed): Broadfin Holdings LLC$23,659,1142026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error
Largest institutional holder #7 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$22,048,2552026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error
Largest institutional holder #8 (13F as filed): WEBER CAPITAL MANAGEMENT LLC /ADV$17,649,3922026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error
Largest institutional holder #9 (13F as filed): Nuveen, LLC$15,603,6492026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error
Largest institutional holder #10 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$13,282,6612026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 07:57 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.